Dexamfetamine, a psychostimulant , is carefully controlled in Australia because of its misuse potential. Its usage is primarily confined to handling of attention-deficit hyperactivity disorder (ADHD) in patients and, less commonly , for narcolepsy . Medical authorizations for dexamfetamine are ri